B. Kolp, D. Abeln, H. Stoeckli-Evans, A. v. Zelewsky
FULL PAPER
HbϪC(9,9Ј)], 2.63 [m,
2
H, HϪC(15,15Ј)], 2.40 [m,
2
H, [{Bis[(؊)-pineno]؊2,2Ј-bipyridine}(N-methylethylenediamine)-
PtII](PF6)2 (61): The synthesis, and purification of compound 61
HϪC(8,8Ј)], 2.15 [d, 2J ϭ 12.0 Hz, 2 H, HaϪC(16,16Ј)], 1.65 [d,
2J ϭ 8.9 Hz, 2 H, HaϪC(17,17Ј)], 1.45 [s, 8 H, H3ϪC(12,12Ј), was carried out as described for compound 11 with L1PtCl2
2
HbϪC(16,16Ј)]; 1.25 [d, J ϭ 8.9 Hz, 2 H, HbϪC(17,17Ј)]; 1.24 [d, (57 mg, 0.093 mmol) and methylethylenediamine (17 µL,
2J ϭ 10.0 Hz, 2 H, HaϪC(9,9Ј)]; 0.67 [s, 6 H, H3ϪC(13,13Ј)]. Ϫ 13C 0.19 mmol) in water/acetone (15 mL). Yield: 50 mg (60%) of 61. Ϫ
NMR (75 MHz, [D3]acetonitrile): δ ϭ 155.2; 154.3; 153.1; 149.0
1H NMR (500 MHz, [D3]acetonitrile): δ ϭ 8.08 [s, 2 H, HϪC(3 or
[C(4,4Ј)], 146.8 [C(6,6Ј)], 124.6 [C(3,3Ј)], 62.5 [C(15,15Ј)], 45.4 3Ј), HϪC(3 or 3Ј)*], 8.07 [s, 2 H, HϪC(3 or 3Ј), HϪC(3 or 3Ј)*],
[C(10,10Ј)], 40.8 [C(8,8Ј)], 36.6 [C(11,11Ј)], 34.3 [C(7,7Ј)], 33.4 8.00 [s, 1 H, HϪC(6 or 6Ј)], 7.99 [s, 1 H, HϪC(6 or 6Ј)*], 7.91 [s,
[C(16,16Ј)], 31.7 [C(9,9Ј)], 25.9 [C(12,12Ј)], 24.6 [C(17,17Ј)], 21.5 2 H, HϪC(6 or 6Ј), HϪC(6 or 6Ј)*], 5.64 [b, 2 H, HϪN(14),
[C(13,13Ј)], (the aromatic quaternary carbon atoms could not be
HϪN(14)*], 5.22 [b, 2 H, HbϪN(14Ј), HbϪN(14Ј)*], 5.13 [b, 2 H,
assigned). Ϫ FAB-MS: m/z (%) ϭ 799 (9) [Mϩ Ϫ PF6], 652 (13) HaϪN(14Ј), HaϪN(14Ј)*], 3.17 [d, 3J ϭ 2.5 Hz, 10 H, H2ϪC(7,7Ј),
[Mϩ Ϫ 2 PF6], 631 (14), 327 (100).
H2ϪC(7,7Ј)*, HbϪC(15), HbϪC(15)*], 3.06 [m, 6 H, H2ϪC(15Ј),
H2ϪC(15Ј)*, HϪC(10 or 10Ј), HϪC(10 or 10Ј)*], 2.96 [dd, 3J ϭ
5.5, 5.5 Hz, 2 H, HϪC(10 or 10Ј), HϪC(10 or 10Ј)*], 2.86 [d, 3J ϭ
6.7 Hz, 3 H, H3CϪN(14)], 2.85 [d, 3J ϭ 6.7 Hz, 3 H, H3CϪN(14)*
], 2.82 [m, 4 H, HbϪC(9), HbϪC(9Ј), HbϪC(9)*, HbϪC(9Ј)*], 2.68
[d, 2J ϭ 9.6 Hz, 2 H, HaϪC(15), HaϪC(15)*], 2.40 [m, 4 H,
HϪC(8), HϪC(8Ј), HϪC(8*), HϪC(8Ј)*], 1.46 [s, 6 H, H3ϪC(12
or12Ј), H3ϪC(12 or12Ј)*], 1.44 [s, 3 H, H3ϪC(12 or 12Ј)*], 1.43 [s,
3 H, H3ϪC(12 or 12Ј)*], 1.24 [m, 4 H, HaϪC(9), HaϪC(9Ј),
HaϪC(9)*, HaϪC(9Ј)*], 0.69 [s, 3 H, H3ϪC(13 or 13Ј), 0.67 [s, 3
H, H3ϪC(13 or 13Ј)*], 0.66 [s, 3 H, H3ϪC(13 or 13Ј)*], 0.65 [s, 3
H, H3ϪC(13 or 13Ј)*]. Ϫ 13C NMR (125 MHz, [D3]acetonitrile):
δ ϭ 155.6, 153.5, 149.4, 149.3, 148.8, 146.7, 146.3 [C(6 or 6Ј), 146.0
[C(6 or 6Ј)], 124.3 [C(3 or 3Ј)], 124.2 [C(3 or 3Ј)], 57.8 [C(15)], 45.5
[C(10 or 10Ј)], 45.3 [C(10 or 10Ј)], 43.9 [C-(15Ј)], 41.7 [CϪN(14)],
41.6 [(CϪN(14)*], 40.3 [C(8 or 8Ј)], 40.2 [C(8 or 8Ј)], 39.7 [C(11 or
11Ј)*], 39.6 [C(11 or 11Ј)*], 34.1 [C(7), C(7Ј)], 31.5 [C(9 or 9Ј)], 31.4
[C(9 or 9Ј)], 25.8 [C(12 or 12Ј)], 25.7 [C(12 or 12Ј)], 21.5 [C(13 or
[{Bis[(؊)-pineno]؊2,2Ј-bipyridine}(S,S/R,R-DACH)PtII](PF6)2 (41):
The synthesis, and purification of compound 41 was carried out as
described for compound 21 with L1PtCl2 (105 mg, 0.17 mmol),
(S,S)-diaminocyclohexane (23 mg, 0.20 mmol), and (R,R)-diamino-
cyclohexane (23 mg, 0.20 mmol) in water/acetone (25 mL). Yield:
1
115 mg (71%). Ϫ H NMR (300 MHz, [D3]acetonitrile): δ ϭ 8.07
[s, 2 H, HϪC(3,3Ј)], 8.00 [s, 2 H, HϪC(6,6Ј)], 5.38 [b, 2 H,
3
HbϪN(14,14Ј)], 4.77 [b, 2 H, HaϪN(14,14Ј)], 3.17 [d, J ϭ 3.4 Hz,
4 H, H2ϪC(7,7Ј)], 2.96 [m, 2 H, HϪC(10,10Ј)], 2.83 [ddd, 2J ϭ
11.2 Hz, 3J ϭ 5.2, 5.2 Hz, 2 H, HbϪC(9,9Ј)], 2.63 [m, 2 H,
2
HϪC(15,15Ј)], 2.40 [m, 2 H, HϪC(8,8Ј)], 2.15 [d, J ϭ 12.0 Hz, 2
2
H, HaϪC(16,16Ј)], 1.65 [d, J ϭ 8.9 Hz, 2 H, HaϪC(17,17Ј)], 1.45
2
[s, 8 H, H3ϪC(12,12Ј), HbϪC(16,16Ј)], 1.25 [d, J ϭ 8.9 Hz, 2 H,
2
HbϪC(17,17Ј)], 1.24 [d, J ϭ 11.2 Hz, 2 H, HaϪC(9,9Ј)], 0.67 [s, 6
H, H3ϪC(13,13Ј)]. Ϫ 13C NMR (75 MHz, [D3]acetonitrile): δ ϭ
155.1, 154.4, 153.3, 148.9 [C(4,4Ј)], 146.7 [C(6,6Ј)], 124.1 [C(3,3Ј)],
62.5 [C(15,15Ј)], 45.2 [C(10,10Ј)], 40.3 [C(8,8Ј)], 36.7 [C(11,11Ј)],
34.2 [C(7,7Ј)], 33.2 [C(16,16Ј)], 31.6 [C(9,9Ј)], 25.8 [C(12,12Ј)], 24.8
[C(17,17Ј)], 21.5 [C(13,13Ј)]. Ϫ FAB-MS: m/z (%) ϭ 798 (25) [Mϩ
Ϫ PF6], 654 (75) [Mϩ Ϫ 2 PF6], 541 (19) [Mϩ Ϫ DACH], 326 (21),
307 (83), 248 (30), 154 (100).
13Ј)], 21.4 [C(13 or 13Ј)]. Ϫ FAB-MS: m/z (%) ϭ 758 (12) [Mϩ
Ϫ
PF6], 612 (51) [Mϩ Ϫ 2 PF6], 598 (11) [Mϩ Ϫ CH3], 538 (21) [Mϩ
Ϫ en], 307 (100). Ϫ The asterisk * denotes NMR signals of the
other possible diastereomers.
[{Bis[(؊)-pineno]؊2,2Ј-bipyridine}(piperazine)PtII](PF6)2 (71): The
synthesis, and purification of compound 71 was carried out as de-
scribed for compound 11 with L1PtCl2 (56 mg, 0.092 mmol) and
piperazine (14 mg, 0.16 mmol) in water/acetone (20 mL). Yield:
30 mg (36%). Ϫ 1H NMR (360 MHz, [D3]acetonitrile): δ ϭ 8.37 [s,
PtϪHJ ϭ 33.5 Hz, 2 H, HϪC(6,6Ј)], 8.04 [s, 2 H, HϪC(3,3Ј)], 5.73
[{Bis[(؊)-pineno]؊2,2Ј-bipyridine}(N,NЈ-dimethylethylenediamine)-
PtII](PF6)2 (51): The synthesis, and purification of compound 51
was carried out as described for compound 11 with L1PtCl2
(60 mg, 0.098 mmol) and dimethylethylenediamine (20 µL,
0.18 mmol) in water/acetone (20 mL). Yield: 55 mg (61%). Ϫ 1H
NMR (500 MHz, [D3]acetonitrile): δ ϭ 8.09 [s, 4 H, HϪC(3,3Ј),
HϪC(3,3Ј)*], 8.06 [s, 0.30 H, HϪC(3,3Ј)*], 8.03 [s, 0.30 H,
HϪC(3,3Ј)*], 7.97 [s, 2 H, HϪC(6,6Ј)], 7.96 [s, 2 H, HϪC(6,6Ј)*],
7.95 [s, 0.30 H, HϪC(6,6Ј)*], 7.94 [s, 0.30 H, HϪC(6,6Ј*), 5.78 [b,
2
[b, 2 H, HϪN(14,14Ј)], 3.78 [d, J ϭ 7.0 Hz, 4 H, HbϪC(15,15Ј),
HbϪC(16,16Ј)], 3.19 [d, 3J ϭ 2.3 Hz, 4 H, H2ϪC(7,7Ј)], 3.00 [d,
2J ϭ 7.0 Hz, 4 H, HaϪC(15,15Ј), HaϪC(16,16Ј)], 2.95 [dd, 3J ϭ 5.1,
2
2
3
0.30 H, HϪN(14,14Ј)*], 5.60 [b, 4 H, HϪN(14,14Ј)], 3.47 [d, J ϭ
5.1 Hz, 2 H, HϪC(10,10Ј)], 2.84 [dd, J ϭ 10.0 Hz, J ϭ 5.1 Hz, 2
H, HbϪC(9,9Ј)], 2.41 [m, H, HϪC(8,8Ј)], 1.47 [s, H,
3
8.8 Hz, 4 H, HaϪC(15,15Ј), HaϪC(15,15Ј)*], 3.19 [d, J ϭ 2.3 Hz,
2
6
8 H, H2ϪC(7,7Ј), H2ϪC(7,7Ј)*], 3.04 [dd, 3J ϭ 5.4, 5.4 Hz, 4 H,
2
H3ϪC(12,12Ј)], 1.25 [d, J ϭ 10.0 Hz, 2 H, HaϪC(9,9Ј)], 0.69 [s, 6
H, H3ϪC(13,13Ј)].
HϪC(10,10Ј), HϪC(10,10Ј)*], 2.89 [d, 3J
ϭ
6.5 Hz,
6 H,
H3ϪC(N14,14Ј)], 2.88 [d, 3J ϭ 6.5 Hz, 6 H, H3ϪC(N14,14Ј)*], 2.83
[dd, 2J ϭ 9.9 Hz, 3J ϭ 5.4 Hz, 4 H, HbϪC(9,9Ј), HbϪC(9,9Ј)*], [{Bis[(؊)-pineno؊2,2Ј-bipyridine}(homopiperazine)PtII](PF6)2 (81):
2.65 [d, 2J ϭ 8.8 Hz, 4 H, HbϪC(15,15Ј), HbϪC(15,15Ј)*], 2.40 [m, The synthesis, and purification of compound 81 was carried out as
4 H, HϪC(8,8Ј), HϪC(8,8Ј)*], 1.46 [s, 6 H, H3ϪC(12,12Ј)], 1.45 [s, described for compound 11 with L1PtCl2 (100 mg, 0.16 mmol) and
6 H, H3ϪC(12,12Ј)*], [1.25 [d, 2J ϭ 9.9 Hz, 2 H, HaϪC(9,9Ј)], 1.23
homopiperazine (50 mg, 0.5 mmol) in water/acetone (30 mL).
[d, 2J ϭ 9.9 Hz, 2 H, HaϪC(9,9Ј)*], 0.68 [s, 6 H, H3ϪC(13,13Ј), Yield: 110 mg (72%). Ϫ 1H NMR (500 MHz, [D3]acetonitrile): δ ϭ
0.66 [s, 6 H, H3ϪC(13,13Ј)*]. Ϫ 13C NMR (125 MHz, [D3]aceton-
8.28 [s, 1 H, HϪC(6 or 6Ј)], 8.27 [s, 1 H, HϪC(6 or 6Ј)], 8.06 [s, 2
itrile): δ ϭ 155.7 [C(2, 4 or 5)], 155.6 [C(2, 4 or 5)*], 153.6 [C(2, 4 H, HϪC(3,3Ј)], 6.06 (b, 1 H, HϪN(14 or 14Ј)],)], 6.03 [b, 1 H,
or 5)], 153.5 [C(2, 4 or 5)*], 149.4 [C(2, 4 or 5)], 149.3 [C(2, 4 or HϪN(14 or 14Ј)], 3.61 [m, 2 H, HbϪC(16,16Ј)], 3.49 [m, 2 H,
3
5)*], 146.1 [C(6,6Ј), 145.9 [C(6,6Ј)*], 124.8 [C(3,3Ј)], 54.1 HbϪC(15,15Ј)], 3.36 [m, 2 H, HaϪC(16,16Ј)], 3.18 [d, J ϭ 2.4 Hz,
[C(15,15Ј)], 45.5 [C(10,10Ј)], 45.3 [C(10,10Ј)*], 43.6 [CϪN(14,14Ј)],
43.5 (CϪN(14,14Ј)*], 40.2 [C(8,8Ј)], 40.1 [C(11,11Ј)*], 34.1
4 H, H2ϪC(7,7Ј)], 2.98 [m, 4 H, HaϪC(15, 15Ј), HϪC(10,10Ј)],
2.82 [dd, J ϭ 9.9 Hz, J ϭ 5.8 Hz, 2 H, HbϪC(9,9Ј)], 2.40 [m, 2
2
3
[C(7,7Ј)], 34.0 [C(7,7Ј)*], 31.5 [C(9,9Ј)], 31.4 [C(9,9Ј)*], 25.8 H, HϪC(8,8Ј)], 2.14 [m, 2 H, H2ϪC-(17)], 1.46 [s, 3 H, H3ϪC(12
2
[C(12,12Ј)], 25.7 [C(12,12Ј)*], 21.5 [C(13,13Ј)], 21.4 [C(13,13Ј)*]. Ϫ or 12Ј)], 1.45 [s, 3 H, H3ϪC(12 or 12Ј)], 1.24 [d, J ϭ 9.9 Hz, 2 H,
FAB-MS: m/z (%) ϭ 772 (10) [Mϩ Ϫ PF6], 627 (44) [Mϩ Ϫ 2 PF6],
598 (13) [Mϩ Ϫ 2 CH3], 537 (17), 460 (26), 307 (100). Ϫ The aster-
isk * denotes NMR signals of the other possible diastereomers.
HaϪC(9,9Ј)], 0.68 [s, 6 H, H3ϪC(13,13Ј)]. Ϫ 13C NMR (125 MHz,
[D3]acetonitrile): δ ϭ 153.9 [C(2,2Ј)], 151.9 [C(5 or 5Ј)], 151.8 [C(5Ј
or 5)], 147.4 [C(4 or 4Ј)], 147.3 [C(4Ј or 4)], 146.2 [C(6 or 6Ј)], 146.1
1216
Eur. J. Inorg. Chem. 2001, 1207Ϫ1220